The findings demonstrate the continued and expanded capabilities of Caris' comprehensive database to enable novel insights into cancer that could have profound effects on a patient's diagnosis ...

"We are proud to present innovative research for prostate cancer and urothelial carcinoma at the upcoming ASCO GU meeting," said James Hamrick, MD, MPH, Chairman of the Caris Precision Oncology ...

The study characterized plasma cell-free DNA (cfDNA) variants of tumor, CH or germline origin in 16,812 patients with advanced cancer using Caris Assure, which sequences both the plasma and buffy ...

"We are proud to present innovative research for prostate cancer and urothelial carcinoma at the upcoming ASCO GU meeting," said James Hamrick, MD, MPH, Chairman of the Caris Precision Oncology ...

LeVert tallied 18 points (6-11 FG, 3-7 3Pt, 3-4 FT), eight rebounds and two assists over 32 minutes during Monday's 112-106 win over Orlando. LeVert finished Monday's game as the Hawks' second ...

LeVert (recently traded) has been ruled out for Friday's game against the Bucks. LeVert was traded to the Hawks ahead of Thursday's NBA trade deadline and will not make his debut Friday for Atlanta.

Feb. 7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to ... Personalized Cancer ...

He noted that Atlanta would be willing to trade De’Andre Hunter for Caris LeVert. As the #1 seed in the East, Cleveland wants to have the right pieces for the postseason. Will they get a deal ...

If the Cavaliers do make a trade, one name has repeatedly come up as a possible candidate who could be moved: Caris LeVert. Let's start with the on-the-floor production. LeVert is currently ...

Georges Niang and Caris LeVert were traded to the Hawks for De’Andre Hunter, and they’re leaving a team that was one of the best in the league this season. For a team like the Hawks ...

Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive ...